PortfoliosLab logo

BioCardia, Inc. (BCDA)

Equity · Currency in USD · Last updated Sep 16, 2022

Company Info

ISINUS09060U5074
CUSIP09060U507
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.90
Year Range$1.18 - $3.58
EMA (50)$1.69
EMA (200)$1.95
Average Volume$67.76K
Market Capitalization$32.32M

BCDAShare Price Chart


Chart placeholderClick Calculate to get results

BCDAPerformance

The chart shows the growth of $10,000 invested in BioCardia, Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $221 for a total return of roughly -97.79%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%AprilMayJuneJulyAugustSeptember
-3.07%
-12.55%
BCDA (BioCardia, Inc.)
Benchmark (^GSPC)

BCDAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M20.83%-9.21%
6M1.50%-10.48%
YTD4.64%-18.15%
1Y-28.52%-12.19%
5Y-48.98%11.13%
10Y-14.11%11.80%

BCDAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-4.64%11.89%0.00%-25.60%9.09%-13.69%-0.00%37.24%2.01%
202118.79%-5.60%11.86%-18.43%15.54%-2.93%-16.37%-11.14%6.44%-10.83%-26.79%-5.37%
202027.72%-21.91%-7.63%40.12%-14.32%-41.03%4.17%-6.00%-3.40%-12.33%18.09%47.23%
201910.00%7.58%-4.93%-8.89%-15.45%1.50%78.95%-71.00%-30.63%24.01%8.46%-20.00%
201816.17%-18.32%-15.70%-25.53%3.57%-5.52%-2.92%-0.75%114.47%-10.63%-28.85%-33.33%
2017-27.08%-17.47%-30.76%-11.80%-11.82%88.57%-13.64%-0.00%-18.42%-9.68%-20.63%-41.25%
2016-0.00%-1.25%13.92%-13.33%76.28%10.55%-7.89%-0.43%-13.99%34.28%130.12%191.50%
20154.76%9.09%-16.67%0.00%6.00%-13.11%-2.28%-10.00%-4.63%-1.62%-10.53%17.65%
20143.57%9.20%-9.47%-5.81%30.86%0.00%3.77%27.18%-7.08%-15.38%-9.09%5.00%
201320.69%28.57%3.33%2.80%-26.78%14.29%0.00%12.50%11.11%40.00%-21.43%-23.64%
201248.57%-36.54%21.21%-12.50%-2.86%0.00%25.00%-17.65%0.00%42.86%-25.00%-22.67%
201163.04%-6.67%-14.43%0.17%16.67%14.29%50.00%-8.33%-4.55%-4.76%-20.00%-12.50%
20105.88%-1.11%-43.82%70.00%-11.76%-20.00%-16.67%-14.00%-6.98%-66.25%-40.74%-42.50%

BCDASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioCardia, Inc. Sharpe ratio is -0.32. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.32
-0.60
BCDA (BioCardia, Inc.)
Benchmark (^GSPC)

BCDADividend History


BioCardia, Inc. doesn't pay dividends

BCDADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-98.41%
-18.66%
BCDA (BioCardia, Inc.)
Benchmark (^GSPC)

BCDAWorst Drawdowns

The table below shows the maximum drawdowns of the BioCardia, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioCardia, Inc. is 99.07%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.07%Jan 5, 20171309May 11, 2022
-95.92%Apr 27, 201089Dec 21, 20101008Dec 29, 20161097
-58.33%Feb 16, 201012Mar 8, 201022Apr 26, 201034
-40%Jan 19, 20101Jan 19, 20104Feb 3, 20105
-32.94%Jan 13, 20101Jan 13, 20101Jan 14, 20102
-0.93%Jan 3, 20171Jan 3, 20171Jan 4, 20172

BCDAVolatility Chart

Current BioCardia, Inc. volatility is 66.04%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%AprilMayJuneJulyAugustSeptember
66.04%
30.28%
BCDA (BioCardia, Inc.)
Benchmark (^GSPC)